Skip to main content

Torley Helen's Form 4 filing

Halozyme Therapeutics, Inc. (HALO) · filed Sep 4, 2025

Accession no.
0001415889-25-023720
Filed
Sep 4, 2025
Trade date
Sep 2-4, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 11 non-derivative transactions and 3 derivative transactions. Open-market sales total $4.44M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Torley HelenCIK 0001528185Director, Officer (PRESIDENT AND CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 2, 2025Common StockMOption exerciseAcquired+20,000$8.11+$162,200753,719Direct
Sep 2, 2025Common StockSSaleDisposed−300$72.49−$21,747753,419Direct
Sep 2, 2025Common StockSSaleDisposed−16,288$73.70−$1,200,425.6737,131Direct
Sep 2, 2025Common StockSSaleDisposed−3,412$74.15−$252,999.8733,719Direct
Sep 3, 2025Common StockMOption exerciseAcquired+20,000$8.11+$162,200753,719Direct
Sep 3, 2025Common StockSSaleDisposed−9,500$74.22−$705,090744,219Direct
Sep 3, 2025Common StockSSaleDisposed−10,500$74.63−$783,615733,719Direct
Sep 4, 2025Common StockMOption exerciseAcquired+20,000$8.11+$162,200753,719Direct
Sep 4, 2025Common StockSSaleDisposed−9,900$73.54−$728,046743,819Direct
Sep 4, 2025Common StockSSaleDisposed−7,800$74.33−$579,774736,019Direct
Sep 4, 2025Common StockSSaleDisposed−2,300$75.22−$173,006733,719Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 2, 2025Common StockMOption exerciseDisposed−20,000$8.11−$162,200176,569Direct
Sep 3, 2025Common StockMOption exerciseDisposed−20,000$8.11−$162,200156,569Direct
Sep 4, 2025Common StockMOption exerciseDisposed−20,000$8.11−$162,200136,569Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)